132 filings
Page 2 of 7
8-K
rv61ti 0ayv
30 Mar 23
Changes in Registrant's Certifying Accountant
7:02am
8-K
7t3u6
23 Mar 23
Kiora Pharmaceuticals Reports 2022 Financial Results; Provides Update on Clinical Development Progress
7:03am
8-K
fhp2iv h796oxp6sr9
7 Feb 23
Kiora Pharmaceuticals Receives Approval for Phase 2 Study of KIO-101 for Treatment of Ocular Presentation of Autoimmune Diseases
7:01am
8-K
9jy6lg 1one9
3 Feb 23
Kiora Pharmaceuticals Enters Into Two Equity Purchase Agreements with Lincoln Park Capital
7:01am
8-K
bc0ke3zc1gxl
9 Jan 23
Regulation FD Disclosure
4:31pm
8-K
d0j1sb13
3 Jan 23
Other Events
4:31pm
8-K
hme rpjxetcrs1xa1beh
21 Nov 22
Kiora Pharmaceuticals Enters Into Agreements to Raise $3.12 Million
7:00am
8-K
ai292e1
13 Oct 22
Other Events
6:45am
8-K
nhxvna8hb7dicvzg
26 Sep 22
Material Modifications to Rights of Security Holders
6:45am
8-K
dikd2h rvh296fsjhs
23 Sep 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
163w fsigx50q60
16 Sep 22
Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance
4:30pm
8-K
we4o32eld 2xgtd
25 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
8-K
fipvga
4 Aug 22
Amendments to Articles of Incorporation or Bylaws
4:36pm
8-K
fm3cos1 69vy2r
26 Jul 22
Kiora Pharmaceuticals Announces Pricing of $5.2 Million Underwritten Public Offering
4:31pm
8-K
gj0 mbmyemt4a
21 Jun 22
Departure of Directors or Certain Officers
5:19pm
8-K
jh10l9 zu5
31 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
0ug pf690
23 May 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:30pm
8-K
rxtrcy8kol02qf0
26 Apr 22
Departure of Directors or Certain Officers
6:51am
8-K
n1h 8twkzn1
23 Mar 22
Departure of Directors or Certain Officers
5:00pm
8-K
98tfhzma1g
28 Feb 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am